149 related articles for article (PubMed ID: 10637496)
1. p53 alterations in human leukemia-lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?
Drexler HG; Fombonne S; Matsuo Y; Hu ZB; Hamaguchi H; Uphoff CC
Leukemia; 2000 Jan; 14(1):198-206. PubMed ID: 10637496
[TBL] [Abstract][Full Text] [Related]
2. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
Drexler HG
Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
[TBL] [Abstract][Full Text] [Related]
4. Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research.
Drexler HG; Matsuo AY; MacLeod RA
Leuk Res; 2000 Nov; 24(11):881-911. PubMed ID: 11086173
[TBL] [Abstract][Full Text] [Related]
5. p53 protein accumulation and gene mutations in human glioma cell lines.
Anker L; Ohgaki H; Ludeke BI; Herrmann HD; Kleihues P; Westphal M
Int J Cancer; 1993 Dec; 55(6):982-7. PubMed ID: 8253536
[TBL] [Abstract][Full Text] [Related]
6. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro.
Sen S; Zhou H; Andersson BS; Cork A; Freireich EJ; Stass SA
Cancer Genet Cytogenet; 1995 Jul; 82(1):35-40. PubMed ID: 7627932
[TBL] [Abstract][Full Text] [Related]
7. P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.
Yeargin J; Cheng J; Yu AL; Gjerset R; Bogart M; Haas M
J Clin Invest; 1993 May; 91(5):2111-7. PubMed ID: 8486778
[TBL] [Abstract][Full Text] [Related]
8. Clonal expansion of p53 mutant cells in leukemia progression in vitro.
Wada H; Asada M; Nakazawa S; Itoh H; Kobayashi Y; Inoue T; Fukumuro K; Chan LC; Sugita K; Hanada R
Leukemia; 1994 Jan; 8(1):53-9. PubMed ID: 8289498
[TBL] [Abstract][Full Text] [Related]
9. Frequent mutations in the p53 gene in human myeloid leukemia cell lines.
Sugimoto K; Toyoshima H; Sakai R; Miyagawa K; Hagiwara K; Ishikawa F; Takaku F; Yazaki Y; Hirai H
Blood; 1992 May; 79(9):2378-83. PubMed ID: 1571549
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
11. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
12. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
[TBL] [Abstract][Full Text] [Related]
13. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood.
Wada M; Bartram CR; Nakamura H; Hachiya M; Chen DL; Borenstein J; Miller CW; Ludwig L; Hansen-Hagge TE; Ludwig WD
Blood; 1993 Nov; 82(10):3163-9. PubMed ID: 8219205
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms.
Sakajiri S; Kawamata N; Egashira M; Mori K; Oshimi K
Jpn J Cancer Res; 2001 Oct; 92(10):1048-56. PubMed ID: 11676855
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.
Nomdedéu JF; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J
Haematologica; 1997; 82(5):550-4. PubMed ID: 9407719
[TBL] [Abstract][Full Text] [Related]
17. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.
Hsiao M; Low J; Dorn E; Ku D; Pattengale P; Yeargin J; Haas M
Am J Pathol; 1994 Sep; 145(3):702-14. PubMed ID: 8080050
[TBL] [Abstract][Full Text] [Related]
18. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
19. [Alterations of the p53 gene and clinical features in childhood acute lymphoblastic leukemia].
Kawamua M; Hayashi Y; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Horibe K; Hongo T; Ueda K
Rinsho Ketsueki; 1997 Sep; 38(9):719-26. PubMed ID: 9364861
[TBL] [Abstract][Full Text] [Related]
20. Alterations of p53 and c-myc in the clonal evolution of malignant lymphoma.
Chang H; Benchimol S; Minden MD; Messner HA
Blood; 1994 Jan; 83(2):452-9. PubMed ID: 8286743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
